This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
11 May 2011

Onyx Scientific Wins Phase I API Contract

Cancer Research UK has selected the UK-based API manufacturer to develop the chemistry and perform the GMP synthesis of the API for use in a Phase 1 clinical trial.

Contract research organisation Onyx Scientific announced that it has won a contract from Cancer Research UK to develop the chemistry and perform the GMP synthesis of an API for use in a Phase I trial.

 

The technical team at Onyx Scientific was able to improve the synthetic methodology as well as provide an alternative route for the API, which will potentially help make the project more efficient and cost effective in the long term.

 

Dr. Nigel Westwood, drug supply manager at Cancer Research UK, said, “Having had a very positive experience of using Onyx Scientific’s process development and GMP manufacturing services in the past, they seemed like a strong candidate for this important project.

 

Related News